معرفی
Sunita Nathan, MD is an Associate Professor in the Department of Internal Medicine at Rush Medical College, Rush University. She specializes in Hematology, Oncology, and Cell Therapy, with a focused clinical and research interest in Bone Marrow Transplantation and Cellular Therapy. She practices at the RUSH MD Anderson Cancer Center in Chicago, IL.
Dr. Nathan completed her medical degree at Byramjee Jeejeebhoy Medical College in India, followed by residency in Internal Medicine and fellowship in Hematology/Oncology at John H. Stroger, Jr. Hospital of Cook County. She is board certified in Hematology.
Her research interests span hematopoietic stem cell transplantation, lymphoma, leukemia, transplant complications, cardio-oncology, and cellular therapies. She has contributed extensively to the literature, particularly in the areas of long-term complications post-transplant, including ocular and cardiovascular effects, and the role of physical activity in recovery. Her work often involves collaboration with international consortia such as CIBMTR and EBMT.
Her recent scholarly output shows a strong focus on clinical guidelines, systematic reviews, and expert consensus statements. Key themes include management of graft-versus-host disease, late effects in transplant survivors, and optimizing transplant outcomes. She has also contributed to high-impact clinical trials in AML and myeloma.
- Hematology Certification
Dr. Nathan actively mentors and contributes to clinical education at Rush Medical College. While specific student names are not listed, her role as an Associate Professor implies involvement in training medical students, residents, and fellows. She has received no explicitly mentioned scientific awards in the provided text. Her research is supported through institutional affiliations and collaborative networks.
She is a key member of the bone marrow transplant team at Rush, contributing to both patient care and advancing the field through research and guideline development. Her work bridges clinical practice with academic scholarship, aiming to improve patient understanding and outcomes in complex hematologic conditions.
